Lonza is expanding its viral-based therapeutics business with the construction of a new, cGMP clean room at its Houston, TX operations. Construction and validation of the expansion is expected to be complete in early 2012. The clean room will offer large-scale capacity to support late-stage viral vaccine and gene therapy projects. It will use disposable process systems to support production and fill/finish operations of as many as 2,000 liters. The expansion is part of an effort to reduce cli...